9-Methoxycanthin-6-one-N-oxideCAS# 137739-74-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 137739-74-3 | SDF | Download SDF |
| PubChem ID | 44593495 | Appearance | Yellow powder |
| Formula | C15H10N2O3 | M.Wt | 266.3 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | COC1=CC2=C(C=C1)C3=C4N2C(=O)C=CC4=[N+](C=C3)[O-] | ||
| Standard InChIKey | IADUHWGVUSHTRQ-UHFFFAOYSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. 9-Methoxycanthin-6-one-N-oxide shows cytotoxic activity against a panel of cell lines comprising a number of human cancer cell types. |
9-Methoxycanthin-6-one-N-oxide Dilution Calculator
9-Methoxycanthin-6-one-N-oxide Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.7552 mL | 18.7758 mL | 37.5516 mL | 75.1033 mL | 93.8791 mL |
| 5 mM | 0.751 mL | 3.7552 mL | 7.5103 mL | 15.0207 mL | 18.7758 mL |
| 10 mM | 0.3755 mL | 1.8776 mL | 3.7552 mL | 7.5103 mL | 9.3879 mL |
| 50 mM | 0.0751 mL | 0.3755 mL | 0.751 mL | 1.5021 mL | 1.8776 mL |
| 100 mM | 0.0376 mL | 0.1878 mL | 0.3755 mL | 0.751 mL | 0.9388 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- BIM 187
Catalog No.:BCC5933
CAS No.:137734-88-4
- GR 64349
Catalog No.:BCC5800
CAS No.:137593-52-3
- Bisindolylmaleimide II
Catalog No.:BCC7868
CAS No.:137592-45-1
- Taxifolin 7-O-rhamnoside
Catalog No.:BCN6851
CAS No.:137592-12-2
- [Lys5,MeLeu9,Nle10]-NKA(4-10)
Catalog No.:BCC5994
CAS No.:137565-28-7
- VT-464 racemate
Catalog No.:BCC5399
CAS No.:1375603-36-3
- Poricoic acid B
Catalog No.:BCN8260
CAS No.:137551-39-4
- Poricoic acid A(F)
Catalog No.:BCN3741
CAS No.:137551-38-3
- 1-Benzoylpiperazine
Catalog No.:BCC8456
CAS No.:13754-38-6
- Regiolone
Catalog No.:BCN7193
CAS No.:137494-04-3
- GNE0877
Catalog No.:BCC5369
CAS No.:1374828-69-9
- Rhapontisterone
Catalog No.:BCC8245
CAS No.:137476-71-2
- 7-Methoxy-beta-carboline-1-propionic acid
Catalog No.:BCN2995
CAS No.:137756-13-9
- 12-O-Acetylrosmarinine
Catalog No.:BCN2125
CAS No.:137760-53-3
- Boeravinone E
Catalog No.:BCN4083
CAS No.:137787-00-9
- 2,3-Di(3',4'-methylenedioxybenzyl)-2-buten-4-olide
Catalog No.:BCN1576
CAS No.:137809-97-3
- Valsartan
Catalog No.:BCC5017
CAS No.:137862-53-4
- Valsartan methyl ester
Catalog No.:BCC9189
CAS No.:137863-17-3
- 6-O-Feruloylglucose
Catalog No.:BCN6195
CAS No.:137887-25-3
- ML 239
Catalog No.:BCC3987
CAS No.:1378872-36-6
- Arillatose B
Catalog No.:BCN6196
CAS No.:137941-45-8
- CBB1003
Catalog No.:BCC5524
CAS No.:1379573-88-2
- CBB1007
Catalog No.:BCC4272
CAS No.:1379573-92-8
- Dehydrotolvaptan
Catalog No.:BCC8932
CAS No.:137973-76-3
Cytotoxic and antimalarial constituents of the roots of Eurycoma longifolia.[Pubmed:1800638]
J Nat Prod. 1991 Sep-Oct;54(5):1360-7.
By bioactivity-directed fractionation, five cytotoxic constituents have been characterized from the roots of Eurycoma longifolia collected in Kalimantan, Indonesia. Four canthin-6-one alkaloids, namely, 9-methoxycanthin-6-one, 9-Methoxycanthin-6-one-N-oxide, 9-hydroxycanthin-6-one, and 9-hydroxycanthin-6-one-N-oxide, and one quassinoid, eurycomanone, were found to be cytotoxic principles. Each of these compounds was evaluated against a panel of cell lines comprising a number of human cancer cell types [breast, colon, fibrosarcoma, lung, melanoma, KB, and KB-V1 (a multi-drug resistant cell line derived from KB)] and murine lymphocytic leukemia (P-388). The canthin-6-ones 1-4 were found to be active with all cell lines tested except for the KB-V1 cell line. Eurycomanone was inactive against murine lymphocytic leukemia (P-388) but was significantly active against the human cell lines tested. Two additional isolates, the beta-carboline alkaloids beta-carboline-1-propionic acid and 7-methoxy-beta-carboline-1-propionic acid, were not significantly active with these cultured cells. However, compounds 5 and 7 were found to demonstrate significant antimalarial activity as judged by studies conducted with cultured Plasmodium falciparum strains. The structures of the novel compounds 2-4 and 7 were established by spectral and chemical methods.
